Our work showed that only conjugatable ISG15 (wild type) increased the sensitivity of cisplatin in ovarian cancer cells, while both conjugatable and nonISGylatable mutant ISG15 were involved in CSC‐like characters. Here, ISG15 is linked to ovarian carcinoma.